| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan
|
Rios-Romenets, Silvia
|
|
|
4 |
C |
p. 283-287
|
article
|
| 2 |
Advances in functional magnetic resonance imaging data analysis methods using Empirical Mode Decomposition to investigate temporal changes in early Parkinson's disease
|
Cordes, Dietmar
|
|
|
4 |
C |
p. 372-386
|
article
|
| 3 |
Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease
|
Liu, Li
|
|
|
4 |
C |
p. 602-608
|
article
|
| 4 |
Alzheimer's disease Archimedes condition-event simulator: Development and validation
|
Kansal, Anuraag R.
|
|
|
4 |
C |
p. 76-88
|
article
|
| 5 |
Alzheimer's disease drug development pipeline: 2018
|
Cummings, Jeffrey
|
|
|
4 |
C |
p. 195-214
|
article
|
| 6 |
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
|
Strydom, André
|
|
|
4 |
C |
p. 703-713
|
article
|
| 7 |
Amyloid-associated increases in longitudinal report of subjective cognitive complaints
|
Amariglio, Rebecca E.
|
|
|
4 |
C |
p. 444-449
|
article
|
| 8 |
A novel two-day intervention reduces stress in caregivers of persons with dementia
|
Spalding-Wilson, Kelsey N.
|
|
|
4 |
C |
p. 450-460
|
article
|
| 9 |
A randomized controlled trial of combined executive function and memory training on the cognitive and noncognitive function of individuals with mild cognitive impairment: Study rationale and protocol design
|
Zhang, Haifeng
|
|
|
4 |
C |
p. 556-564
|
article
|
| 10 |
A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study
|
Zhu, Carolyn W.
|
|
|
4 |
C |
p. 609-616
|
article
|
| 11 |
A randomized, single ascending dose study of intravenous BIIB092 in healthy participants
|
Qureshi, Irfan A.
|
|
|
4 |
C |
p. 746-755
|
article
|
| 12 |
A simulation study comparing slope model with mixed-model repeated measure to assess cognitive data in clinical trials of Alzheimer's disease
|
Chen, Yun-Fei
|
|
|
4 |
C |
p. 46-53
|
article
|
| 13 |
Biomedical informatics applications for precision management of neurodegenerative diseases
|
Miller, Justin B.
|
|
|
4 |
C |
p. 357-365
|
article
|
| 14 |
Bridging the gap: From reablement policy to practice for people with dementia
|
Poulos, Roslyn G.
|
|
|
4 |
C |
p. 508-509
|
article
|
| 15 |
Caregivers dying before care recipients with dementia
|
Gaugler, Joseph E.
|
|
|
4 |
C |
p. 688-693
|
article
|
| 16 |
Caregiving, intellectual disability, and dementia: Report of the Summit Workgroup on Caregiving and Intellectual and Developmental Disabilities
|
Heller, Tamar
|
|
|
4 |
C |
p. 272-282
|
article
|
| 17 |
Case-finding in clinical practice: An appropriate strategy for dementia identification?
|
Ranson, Janice M.
|
|
|
4 |
C |
p. 288-296
|
article
|
| 18 |
Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia
|
Willis, Brian A.
|
|
|
4 |
C |
p. 652-660
|
article
|
| 19 |
Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
|
Kirsebom, Bjørn-Eivind
|
|
|
4 |
C |
p. 617-627
|
article
|
| 20 |
Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
|
Ihara, Ryoko
|
|
|
4 |
C |
p. 645-651
|
article
|
| 21 |
Cognitive and structural cerebral changes in amnestic mild cognitive impairment due to Alzheimer's disease after multicomponent training
|
Teixeira, Camila Vieira Ligo
|
|
|
4 |
C |
p. 473-480
|
article
|
| 22 |
Community-based serious illness care for patients with dementia
|
Noah, Hannah
|
|
|
4 |
C |
p. 324-325
|
article
|
| 23 |
Computer Interactive Reminiscence and Conversation Aid groups—Delivering cognitive stimulation with technology
|
Astell, Arlene J.
|
|
|
4 |
C |
p. 481-487
|
article
|
| 24 |
Current understanding of magnetic resonance imaging biomarkers and memory in Alzheimer's disease
|
Bayram, Ece
|
|
|
4 |
C |
p. 395-413
|
article
|
| 25 |
Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology
|
Tournissac, Marine
|
|
|
4 |
C |
p. 677-687
|
article
|
| 26 |
Dietary patterns and β-amyloid deposition in aging Australian women
|
Hill, Edward
|
|
|
4 |
C |
p. 535-541
|
article
|
| 27 |
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials
|
Gold, Michael
|
|
|
4 |
C |
p. 234-242
|
article
|
| 28 |
Discontinuation and nonpublication of interventional clinical trials conducted in patients with mild cognitive impairment and Alzheimer's disease
|
Yilmaz, Taygan
|
|
|
4 |
C |
p. 161-164
|
article
|
| 29 |
Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in Japan
|
Kobayashi, Hiroyuki
|
|
|
4 |
C |
p. 130-136
|
article
|
| 30 |
Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease
|
Hwang, Yun Tae
|
|
|
4 |
C |
p. 103-107
|
article
|
| 31 |
Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study
|
Iwata, Atsushi
|
|
|
4 |
C |
p. 765-774
|
article
|
| 32 |
Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial
|
Jia, Jianping
|
|
|
4 |
C |
p. 108-117
|
article
|
| 33 |
Electrical brain stimulation in different variants of primary progressive aphasia: A randomized clinical trial
|
Tsapkini, Kyrana
|
|
|
4 |
C |
p. 461-472
|
article
|
| 34 |
Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficits
|
Krishnan, Balaji
|
|
|
4 |
C |
p. 89-102
|
article
|
| 35 |
Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
|
Severino, Maurizio
|
|
|
4 |
C |
p. 215-223
|
article
|
| 36 |
Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
|
Taylor, Matthew K.
|
|
|
4 |
C |
p. 28-36
|
article
|
| 37 |
From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting
|
Vanderschaeghe, Gwendolien
|
|
|
4 |
C |
p. 243-251
|
article
|
| 38 |
Galectin-3 and incident cognitive impairment in REGARDS, a cohort of blacks and whites
|
Venkatraman, Anand
|
|
|
4 |
C |
p. 165-172
|
article
|
| 39 |
Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial
|
Deal, Jennifer A.
|
|
|
4 |
C |
p. 499-507
|
article
|
| 40 |
Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tau
|
Rosenqvist, Nina
|
|
|
4 |
C |
p. 521-534
|
article
|
| 41 |
Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease
|
Belitskaya-Lévy, Ilana
|
|
|
4 |
C |
p. 344-349
|
article
|
| 42 |
Inflammation as a central mechanism in Alzheimer's disease
|
Kinney, Jefferson W.
|
|
|
4 |
C |
p. 575-590
|
article
|
| 43 |
Intranasal rifampicin for Alzheimer's disease prevention
|
Umeda, Tomohiro
|
|
|
4 |
C |
p. 304-313
|
article
|
| 44 |
Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: A systematic review
|
Topiwala, Hinesh
|
|
|
4 |
C |
p. 182-194
|
article
|
| 45 |
Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis
|
Ramsey, Christine M.
|
|
|
4 |
C |
p. 1-10
|
article
|
| 46 |
Measuring cognition and function in the preclinical stage of Alzheimer's disease
|
Weintraub, Sandra
|
|
|
4 |
C |
p. 64-75
|
article
|
| 47 |
Minimotifs dysfunction is pervasive in neurodegenerative disorders
|
Sharma, Surbhi
|
|
|
4 |
C |
p. 414-432
|
article
|
| 48 |
Network-based assessment of collaborative research in neuroscience
|
Marchand, Gwen C.
|
|
|
4 |
C |
p. 433-443
|
article
|
| 49 |
Neural correlates of episodic memory in the Memento cohort
|
Epelbaum, Stephane
|
|
|
4 |
C |
p. 224-233
|
article
|
| 50 |
Neurodegeneration research: Advances in clinical translational neuroscience infrastructure and methods
|
Cummings, Jeffrey L.
|
|
|
4 |
C |
p. 326-329
|
article
|
| 51 |
Neuroimaging and neuropsychological assessment of freezing of gait in Parkinson's disease
|
Bluett, Brent
|
|
|
4 |
C |
p. 387-394
|
article
|
| 52 |
Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide–induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggested
|
Blivet, Guillaume
|
|
|
4 |
C |
p. 54-63
|
article
|
| 53 |
Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience
|
Ritter, Aaron
|
|
|
4 |
C |
p. 350-356
|
article
|
| 54 |
Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model
|
Srinivasan, Mythily
|
|
|
4 |
C |
p. 488-498
|
article
|
| 55 |
Objectively measured physical activity profile and cognition in Finnish elderly twins
|
Iso-Markku, Paula
|
|
|
4 |
C |
p. 263-271
|
article
|
| 56 |
Online study partner-reported cognitive decline in the Brain Health Registry
|
Nosheny, Rachel L.
|
|
|
4 |
C |
p. 565-574
|
article
|
| 57 |
Opioid use and the presence of Alzheimer's disease and related dementias among elderly Medicare beneficiaries diagnosed with chronic pain conditions
|
Shen, Chan
|
|
|
4 |
C |
p. 661-668
|
article
|
| 58 |
Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program
|
Saunders, Stina
|
|
|
4 |
C |
p. 694-702
|
article
|
| 59 |
Patient perspectives of the experience of a computerized cognitive assessment in a clinical setting
|
Robillard, Julie M.
|
|
|
4 |
C |
p. 297-303
|
article
|
| 60 |
Person-centered care for older people with dementia in the acute hospital
|
Tay, Felicia Hui En
|
|
|
4 |
C |
p. 19-27
|
article
|
| 61 |
Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States
|
Chen, Cynthia
|
|
|
4 |
C |
p. 510-520
|
article
|
| 62 |
Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease
|
Voss, Tiffini
|
|
|
4 |
C |
p. 173-181
|
article
|
| 63 |
Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
|
Wang, Guoqiao
|
|
|
4 |
C |
p. 669-676
|
article
|
| 64 |
Statistical advances in clinical trials and clinical research
|
Shan, Guogen
|
|
|
4 |
C |
p. 366-371
|
article
|
| 65 |
Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
|
Hu, Ziheng
|
|
|
4 |
C |
p. 542-555
|
article
|
| 66 |
“Text It” program to track falls in patients with Alzheimer's disease and dementia
|
Kamil, Rebecca J.
|
|
|
4 |
C |
p. 137-140
|
article
|
| 67 |
The Age-Well observational study on expert meditators in the Medit-Ageing European project
|
Lutz, Antoine
|
|
|
4 |
C |
p. 756-764
|
article
|
| 68 |
The Age-Well randomized controlled trial of the Medit-Ageing European project: Effect of meditation or foreign language training on brain and mental health in older adults
|
Poisnel, Géraldine
|
|
|
4 |
C |
p. 714-723
|
article
|
| 69 |
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort
|
Tariot, Pierre N.
|
|
|
4 |
C |
p. 150-160
|
article
|
| 70 |
The Cognitive Ageing, Nutrition and Neurogenesis (CANN) trial: Design and progress
|
Irvine, Michael A.
|
|
|
4 |
C |
p. 591-601
|
article
|
| 71 |
The hidden variables problem in Alzheimer's disease clinical trial design
|
Liyanage, S. Imindu
|
|
|
4 |
C |
p. 628-635
|
article
|
| 72 |
The influence of GAPT extraction on synapse loss of APPswe/PS1dE9 transgenic mice via adjusting Bcl-2/Bax balance
|
Shi, Jing
|
|
|
4 |
C |
p. 724-736
|
article
|
| 73 |
The My Active and Healthy Aging (My-AHA) ICT platform to detect and prevent frailty in older adults: Randomized control trial design and protocol
|
Summers, Mathew J.
|
|
|
4 |
C |
p. 252-262
|
article
|
| 74 |
The price of progress: Funding and financing Alzheimer's disease drug development
|
Cummings, Jeffrey
|
|
|
4 |
C |
p. 330-343
|
article
|
| 75 |
The SCD-Well randomized controlled trial: Effects of a mindfulness-based intervention versus health education on mental health in patients with subjective cognitive decline (SCD)
|
Marchant, Natalie L.
|
|
|
4 |
C |
p. 737-745
|
article
|
| 76 |
TOMMORROW neuropsychological battery: German language validation and normative study
|
Romero, Heather R.
|
|
|
4 |
C |
p. 314-323
|
article
|
| 77 |
Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
|
Teich, Andrew F.
|
|
|
4 |
C |
p. 37-45
|
article
|
| 78 |
Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study
|
Edmonds, Emily C.
|
|
|
4 |
C |
p. 11-18
|
article
|
| 79 |
User experience and clinical effectiveness with two wearable global positioning system devices in home dementia care
|
Megges, Herlind
|
|
|
4 |
C |
p. 636-644
|
article
|
| 80 |
Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer's disease risk: A randomized controlled trial
|
Doniger, Glen M.
|
|
|
4 |
C |
p. 118-129
|
article
|
| 81 |
Wishes and preferences for an online lifestyle program for brain health—A mixed methods study
|
Wesselman, Linda M.P.
|
|
|
4 |
C |
p. 141-149
|
article
|
Journal description